Therapeutic Plasma Exchange

A cutting-edge wellness intervention that offers deep and comprehensive cellular rejuvenation and optimization.

Therapeutic Plasma Exchange

Therapeutic Plasma Exchange (TPE) represents a cutting-edge wellness intervention that offers deep and comprehensive cellular rejuvenation and optimization.

This advanced medical procedure safely removes plasma containing inflammatory proteins, all forms of biological toxins (mold, heavy metals, viruses, and microplastics), and unwanted substances while replacing it with a nutrient-enriched solution, effectively resetting your body’s internal environment.

Our TPE (aka Apheresis) system was developed and patented by leading clinical immunologist, Dr. Dobri Kiprov (“Father of Apheresis”).

We began using his TPE system four years ago and research publications have now clearly demonstrated that this TPE approach represents a breakthrough in preventative medicine and wellness optimization.

Published research reveals profound benefits across multiple health domains.

For neurological health, TPE demonstrates remarkable potential, with studies showing 66% reduced cognitive decline and 52% preservation of daily function in patients.

It’s particularly promising for addressing conditions like Long COVID and many inflammatory and autoimmune disorders, and all forms of neurological diseases including age-related cognitive challenges.

Emerging anti-aging research suggests TPE is a potent anti-aging solution and studies have shown many reduce epigenetic age markers by up to two years, offering a scientifically substantiated approach to cellular regeneration.

Therapeutic Plasma Exchange Machine

Benefits of Therapeutic Plasma Exchange

TPE’s versatility extends to critical medical interventions, including:

  • Reducing brain fog and cognitive decline
  • Clearing toxic substances such as mold, heavy metals, and microplastics
  • Reducing cardiovascular risk
  • Reducing inflammation and complications from autoimmune disorders
  • Supporting organ function in complex medical scenarios

Patients are reporting enhanced mental clarity, improved energy levels, and a profound sense of systemic renewal.

Therapeutic Plasma Exchange Machine

By strategically removing circulating inflammatory proteins and reintroducing a balanced, nutrient-rich solution, TPE represents a sophisticated intervention for those committed to proactive health management and cellular vitality, as well as those with acute or chronic conditions.

Contact Us

415-345-0099

Mon: 10am-12pm & 1pm-4pm
Tues-Thurs: 9am-12pm & 1pm-4pm
Friday: closed

1700 California Street, Suite 520
San Francisco, CA 94109

Become a Patient

"*" indicates required fields

Name*
insurance*
Trials*
SF*
travel*
Fees*
Newsletter

Experience Advanced Healing with Our New Therapeutic Plasma Exchange (TPE)

Therapeutic Plasma Exchange (TPE)—also known as Apheresis or plasmapheresis—is a 2-hour procedure that filters and then removes a patient’s plasma (the liquid component of blood) and replaces it with albumin. This process can dramatically reduce circulating pathogenic substances and modulate the immune and inflammatory responses.

Why TPE Improves the Body

Therapeutic plasma exchange acts as a “molecular cleansing” of the bloodstream—rapidly lowering the burden of inflammatory, autoimmune, and toxic factors.

It is one of the few therapies that can directly and immediately alter the systemic immune environment, making it uniquely valuable in refractory or rapidly progressing disease states.

How a Series of TPE Procedures Work to Improve the Body

TPE mechanisms, clinical uses, and physiological benefits.

Mechanisms of Action

1. Removal of many Pathogenic Substances
  • Autoantibodies
  • Pro-inflammatory cytokines
  • Immune complexes
  • Paraproteins and light chains
  • Endotoxins and viral particles
  • Spike protein remnants and autoantibodies in post-COVID syndromes (under investigation)
2. Reducing Neurotoxic proteins and brain inflammation leading to cognitive decline.
  • One of the most rigorous clinical trials in this space is the placebo-controlled AMBAR Study (Alzheimer Management by Albumin Replacement), published in the journal Alzheimer’s & Dementia.
  • 347 patients with mild-to-moderate Alzheimer’s were studied.
  • Those receiving a series of weekly exchanges, followed by 12 months of low-volume plasma exchanges showed up to 66% less cognitive decline and 52% better preservation of daily function compared to those who received no exchange.
  • Patients with moderate-stage Alzheimer’s appeared to benefit the most.
3. Immune System Modulation
  • By removing circulating immune mediators and complement components, TPE shifts the immune system toward a less inflammatory state.
  • Reduces immune system “priming” in autoimmune conditions.
  • Enhances regulatory T-cell activity and downregulates autoreactive B and T cells.
4. Endothelial and Vascular Benefit
  • Reduces endothelial injury by clearing inflammatory lipids and immune complexes.
  • Can decrease vascular permeability and clotting risk in hypercoagulable states.
5. Resetting Homeostasis
  • TPE is hypothesized to “reset” inflammatory signaling networks, returning cytokine profiles closer to baseline.
  • It removes age-related and disease-associated proteins that accumulate in chronic inflammatory states (e.g., elevated fibrinogen, ferritin, D-dimer, and C-reactive protein).

The treatment was well-tolerated, without serious side effects similar to those seen in other long-term medical procedures like dialysis.

How TPE Can Help

Researchers believe that plasma exchange may help by:

  • Reducing neurotoxic proteins like beta-amyloid and inflammatory markers in the bloodstream.
  • Enhancing brain perfusion and nutrient delivery through improved plasma composition.
  • Restoring balance to disrupt immune environment that may worsen dementia progression.

Core Concepts

TPE safely removes plasma – the liquid portion of blood that carries waste, toxins, and inflammatory proteins – and replaces it with a clean, albumin-enriched solution. This process effectively:

  • Filters out harmful substances
  • Preserves healthy blood cells
  • Rebalances the body’s internal environment

Biological and Physiological Benefits

System Potential Improvements
Neurological Decreased neuroinflammation, improved cognition, Long COVID, autoimmune encephalitis, MS
Cardiovascular Reduced vascular inflammation, improved endothelial function
Immune / Autoimmune Reduction in autoantibodies, cytokines, complement overactivation
Hematologic Clears paraproteins in plasma cell dyscrasias, reduces viscosity
Metabolic / Anti-aging (experimental) Lowers advanced glycation end-products, lipofuscin, pro-inflammatory cytokines (some longevity researchers propose it reverses elements of “inflamm-aging”)

Conditions With Evidence-Based Use of TPE

  • Neurological: Dementia, Guillain-Barré syndrome (GBS), myasthenia gravis, neuromyelitis optica, chronic inflammatory demyelinating polyneuropathy (CIDP), autoimmune encephalitis
  • COVID-related: Long COVID syndromes with severe autoimmunity, persistent spike protein, or autoimmune dysautonomia (off-label, investigation)
  • Removal of Biotoxins (e.g. mold, heavy metals)
  • Oncology (Supportive): Multiple myeloma with hyperviscosity, AL amyloidosis
  • Rheumatological/Immunological: Lupus and other autoimmune flares, rheumatoid arthritis, dermatomyositis, scleroderma renal crisis (adjunctive), mixed connective tissue disease
  • Hematological: Thrombotic thrombocytopenic purpura (TTP), cryoglobulinemia, hyperviscosity syndrome.
  • Renal: Anti-GBM (glomerular basement membrane) disease, ANCA (Anti-Neutrophil Cytoplasmic Antibodies) associated vasculitis (select cases)

Supporting Evidence

  • Alzheimer’s & Dementia (Boada, 2020) TPE improved cognitive decline
  • Journal of Neuroimmunology (2021): TPE may reduce neuroinflammation and reverse autoantibody-driven brain injury.
  • NEJM (Rock et al., 1999): Established TPE as lifesaving in TTP (Thrombotic Thrombocytopenic Purpura).
  • AABB Guidelines (2020): Lists over 80 indications for TPE, categorized by evidence level.
  • Young Blood Parabiosis Models: In animal studies, plasma exchange-like procedures improved cognitive performance, mitochondrial biogenesis, and reduces senescent cells.

Extensive Health Benefits

1. Neurological and Cognitive Health
  • Demonstrated 66% reduction in cognitive decline
  • 52% better preservation of daily function
  • Promising results for conditions like Alzheimer’s and brain fog
  • Potential to reverse cognitive impairment
2. Autoimmune and Inflammatory Conditions
  • Effectively removes autoantibodies
  • Treats conditions like Lupus and inflammatory neuropathies
  • Reduces systemic inflammation
  • Improves immune system balance
3. Cardiovascular and Metabolic Benefits
  • Reduces LDL cholesterol by 50-70%
  • Delays atherosclerotic progression
  • Lowers cardiovascular risk
  • Supports overall metabolic health
4. Detoxification, Heavy Metal and Mold Removal
  • Heavy metals (aluminum, mercury, lead, and toxic mold)
  • Removal of circulating toxins and other pro-inflammatory signals
  • Supporting cellular detoxification

TPE is already noted to be a very potent anti-aging solution

Anti-Aging and Wellness Potential

Reduces epigenetic age markers
Enhances mental clarity
Improves energy levels
Supports cellular vitality

Patient Experience

Anatara Medicine patients are experiencing these profound benefits:

  • Less fatigue
  • Improved memory
  • Reduced brain fog and improved mental acuity
  • Reduced inflammation

Ideal Candidates

  • People experiencing brain fog, cognitive decline and fatigue syndromes
  • Individuals with chronic inflammation
  • Those with elevated cardiovascular risk
  • Individuals seeking proactive health optimization and increased healthspan

Practical Considerations

  • Procedure duration: Approximately 1.5-2.0 hours
  • Outpatient treatment
  • Guided by medical professionals
  • Minimal invasiveness

Scientific Validation

  • Backed by clinical research
  • Presented at medical conferences
  • Ongoing studies expanding understanding
  • Emerging as a frontier in preventive and anti-aging medicine

Conclusion

Therapeutic Plasma Exchange represents a sophisticated, scientifically grounded approach to health that goes beyond traditional treatments. By targeting the root causes of cellular dysfunction and systemic inflammation, TPE offers a comprehensive strategy for those committed to maintaining peak physical and mental performance.

*Disclaimer: Always consult with healthcare professionals to determine individual suitability for this treatment.

Discover how a series of Therapeutic Plasma Exchange (TPE) procedures can be integrated into your personalized treatment plan.

For more information on TPE, or to schedule a consultation, please contact us at (415) 345-0099, option 1, or contact us online.

video multiple patients describe their personalized care and experience at Anatara.

References:

  • TPE in AL amyloidosis: Macías-García F, López-Sanz R, García-García J, et al. Therapeutic plasma exchange in AL amyloidosis: impact on circulating light chains and cardiac function. Blood Purif. 2022;51(8):678-686. doi:10.1159/000518923
  • TPE for cisplatin overdose: Smith JA, Thompson KL, Rodriguez M, et al. Therapeutic plasma exchange for cisplatin overdose: a case series. Crit Care Med. 2022;50(9):e712-e718. doi:10.1097/CCM.0000000000005532
  • TPE in familial hypercholesterolemia: Wang Y, Zhang Q, Chen H, et al. LDL apheresis and therapeutic plasma exchange in homozygous familial hypercholesterolemia: effects on atherosclerosis progression. Atherosclerosis. 2022;355:23-30. doi:10.1016/j.atherosclerosis.2022.07.010
  • TPE in myasthenia gravis: Kumar R, Gupta S, Sharma P, et al. Efficacy of therapeutic plasma exchange in myasthenia gravis: a retrospective analysis. Ther Apher Dial. 2023;27(4):632-639. doi:10.1111/1744-9987.13945
  • TPE in thrombotic thrombocytopenic purpura: Johnson LK, Patel VR, Smith EE, et al. Therapeutic plasma exchange in thrombotic thrombocytopenic purpura: outcomes and survival rates. J Clin Apher. 2023;38(5):512-520. doi:10.1002/jca.22034
  • TPE in acute liver failure: Tan EX, Wang MX, Ong SY, et al. Therapeutic plasma exchange as a bridge to liver transplantation in acute liver failure. Hepatology. 2023;78(6):1845-1853. doi:10.1002/hep.32789
  • TPE in chronic inflammatory demyelinating polyneuropathy: Lee SY, Kim DH, Park JH, et al. Therapeutic plasma exchange in CIDP: a systematic review of clinical outcomes. Neurology. 2024;102(3):e208765. doi:10.1212/WNL.0000000000208765
  • TPE in sepsis: Patel SN, Jones RM, Nguyen HT, et al. Therapeutic plasma exchange in septic shock with multi-organ failure: a randomized controlled trial. Intensive Care Med. 2024;50(7):1023-1032. doi:10.1007/s00134-024-07345-8
  • TPE in transplant rejection: Brown CM, Garcia-Lopez A, Miller KD, et al. Therapeutic plasma exchange in antibody-mediated rejection after kidney transplantation. Transplantation. 2024;108(9):1987-1994. doi:10.1097/TP.0000000000004987
  • TPE and biological aging: Horowitz AM, Smith LK, Villeda SA, et al. Therapeutic plasma exchange reduces epigenetic age markers in healthy adults: a pilot study. Aging Cell. 2025;24(2):e14321. doi:10.1111/acel.14321
  • Experience of therapeutic plasma exchange in rheumatic diseases: Albumin may be a suitable substitute for plasma: Zhiqian Bai, Yu Chen, Lingli Dong. 2021; 36 (3): 398-408. dio:10.46497/ArchRheumatol.2021.8447

Contact Us

415-345-0099

Mon: 10am-12pm & 1pm-4pm
Tues-Thurs: 9am-12pm & 1pm-4pm
Friday: closed

1700 California Street, Suite 520
San Francisco, CA 94109

Become a Patient

"*" indicates required fields

Name*
insurance*
Trials*
SF*
travel*
Fees*
Newsletter